Hematopoietic Stem Cell Transplantation for Multiple Myeloma

摘要

Objective; To provide an overview of the hematopoietic stem cell transplantation (HSGT) process specific to patients with multiple myeloma (MM) and their caregivers. Data Sources: Research studies, book chapters, websites, expert knowledge, and journal articles. Conclusion: Although not curative, autologous HSCT is an important, manageable treatment modality, and continues to be a standard of care in MM for those patients who are eligible. Implications for Nursing Practice: Although an area of specialty practice, an understanding of the HSCT process is important to broaden the knowledge of all nurses who care for patients with MM.